{"id":709041,"date":"2026-08-19T15:16:03","date_gmt":"2026-08-19T15:16:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=709041"},"modified":"2026-08-19T15:16:03","modified_gmt":"2026-08-19T15:16:03","slug":"un-pas-inainte-pentru-vaccinul-impotriva-cancerului-de-piele-moderna-si-merck-au-anuntat-primele-rezultate-promitatoare","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=709041","title":{"rendered":"Un pas \u00eenainte pentru vaccinul \u00eempotriva cancerului de piele. Moderna \u0219i Merck au anun\u021bat primele rezultate promi\u021b\u0103toare"},"content":{"rendered":"<div readability=\"44.809497515185\">\n<div class=\"sgb-google-buttons\">\n<div class=\"display-flex justify-center google-logo\"><img decoding=\"async\" loading=\"lazy\" class=\"mg-x-auto\" width=\"30\" height=\"30\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/08\/un-pas-inainte-pentru-vaccinul-impotriva-cancerului-de-piele-moderna-si-merck-au-anuntat-primele-rezultate-promitatoare.png\" alt><\/div>\n<\/p><\/div>\n<p id=\"p-0\">Gigan\u021bii farmaceutici Moderna \u0219i Merck au declarat, miercuri, \u00eentr-un comunicat de pres\u0103, c\u0103 un tratament experimental cu vaccin a dat semne c\u0103 ar putea preveni reapari\u021bia sau r\u0103sp\u00e2ndirea cancerului, \u00een cadrul unui studiu realizat pe pacien\u021bi cu melanom cu risc ridicat.<\/p>\n<p id=\"p-1\">Vaccinul, care are la baz\u0103 tehnologia ARN mesager (ARNm), a fost testat \u00eentr-un studiu clinic \u00een stadiu avansat, care a implicat persoane care suferiser\u0103 deja o interven\u021bie chirurgical\u0103 pentru \u00eendep\u0103rtarea unui melanom, cea mai letal\u0103 form\u0103 de cancer de piele.<\/p>\n<p id=\"p-2\">Studiul a inclus 1.137 de pacien\u021bi cu risc ridicat, cu melanom \u00een stadiile IIB-IV, care fusese \u00eendep\u0103rtat chirurgical.<\/p>\n<p id=\"p-3\">Studiul a implicat un vaccin personalizat \u00eempotriva cancerului, denumit Intismeran, produs de Merck \u0219i Moderna, utilizat \u00een combina\u021bie cu Keytruda, imunoterapia \u00eempotriva cancerului dezvoltat\u0103 de Merck, potrivit <span><a href=\"https:\/\/www.nbcnews.com\/health\/health-news\/merck-moderna-say-melanoma-vaccine-promise-prevent-recurrence-cancer-rcna593316?cid=sm_npd_nn_tw_ma&amp;taid=6a85ae34ff73fd0001d3778f\" target=\"_blank\" rel=\"noopener\">NBC News.<\/a><\/span><\/p>\n<p id=\"p-4\">\u201eAceste rezultate din faza 3 reprezint\u0103 un moment crucial pentru domeniul cercet\u0103rii \u00een domeniul cancerului. Timp de mul\u021bi ani, ideea cre\u0103rii unui tratament pe baz\u0103 de ARNm conceput special pentru cancerul unui pacient anume a fost o aspira\u021bie. Acum contribuim la transformarea acestei viziuni \u00een realitate\u201d, a declarat St\u00e9phane Bancel, CEO al Moderna, \u00een comunicat.<\/p>\n<p id=\"p-5\">Companiile au descris acest lucru ca fiind prima descoperire de acest gen. Ele au precizat c\u0103 studiul va continua s\u0103 examineze ratele de supravie\u021buire global\u0103 dup\u0103 tratament.<\/p>\n<p id=\"p-6\">Cele dou\u0103 companii au subliniat c\u0103 toate aceste date vor fi prezentate la o viitoare conferin\u021b\u0103 medical\u0103 \u0219i vor fi comunicate autorit\u0103\u021bilor de reglementare.<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Gigan\u021bii farmaceutici Moderna \u0219i Merck au declarat, miercuri, \u00eentr-un comunicat de pres\u0103, c\u0103 un tratament experimental cu vaccin a dat semne c\u0103 ar putea preveni reapari\u021bia sau r\u0103sp\u00e2ndirea cancerului, \u00een &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=709041\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":709042,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/709041"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=709041"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/709041\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/709042"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=709041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=709041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=709041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}